查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1832355

腦監測設備市場（按技術、應用、最終用戶和產品類型）—2025-2032 年全球預測

Brain Monitoring Devices Market by Technology, Application, End User, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腦監測設備市場規模將成長至 51.5 億美元，複合年成長率為 7.74%。

主要市場統計數據
基準年2024年 28.4億美元
預計2025年 30.6億美元
預測年份：2032年 51.5億美元
複合年成長率（%） 7.74%

簡潔、前瞻性地介紹了重塑臨床和研究環境中大腦監測的技術、臨床和護理服務變化。

隨著感測技術、計算分析和醫療服務模式的進步，腦監測設備領域正在快速發展，並重新定義神經系統評估和持續監測。臨床醫生正在尋求能夠增強診斷信心，同時又能適應日益分散的醫療路徑的工具。同時，研究人員和設備開發者正在改進監測模式，以減少獲得醫療服務的障礙，提高患者舒適度，並將監測範圍從偶發性診療擴展到縱向、真實世界的數據收集。

同時，訊號處理、微型感測器和低視野成像平台的改進也為新的設備形態和用例創造了機會。軟體主導分析技術的日益成熟，進一步擴大了這些技術的可能性，將原始生理訊號轉化為可用於診斷、治療計劃和結果追蹤的可行洞察。因此，醫療保健、研究和居家照護領域的相關人員正在重新評估其臨床工作流程和採購優先級，以尋求兼顧性能、易用性和成本效益的解決方案。

監管途徑和報銷環境也不斷調整，迫使製造商和醫療保健提供者將其產品開發和證據產生策略與臨床需求緊密結合。這些動態正在加速從單純以醫院為中心的影像和監護模式向集醫院、門診和家庭監護於混合模式的轉變，從而擴大腦監護設備在急性和慢性護理管理中的作用。

技術創新、分析突破和護理服務轉變正在匯聚，改變大腦監測能力和應用

近年來，一系列變革性變化正在重新定義腦監測設備的功能及其部署場景。其中一個關鍵變化是從大型固定式裝置轉向攜帶式穿戴式平台的轉變，這些平台能夠在傳統臨床環境之外實現持續或動態監測。伴隨這一轉變，多模態方法也蓬勃發展，這些方法將腦電圖與光學、磁學和代謝成像相結合，提供腦功能的互補觀點。

另一個重大轉變是高階分析技術的整合，包括機器學習和雲端基礎流程，將複雜的生理資料集轉化為臨床相關的輸出。這些分析技術能夠實現更快的解讀、跨大樣本群體的模式識別以及預測模型，從而支持早期療育。同時，緊湊型感測器陣列、低場磁振造影系統和光激發磁強計等硬體創新正在降低成本、佔用空間和操作複雜性，從而降低應用門檻。

生態系層面的變化也值得關注。居家醫療和門診使用的興起，將重點轉向患者的便利性和長期監測，因此需要更加重視設備的舒適性、資料安全性和遠端設備管理。供應鏈的多樣化和本土化正在影響製造策略，而不斷變化的監管預期則要求進行嚴格的臨床檢驗和上市後監測。這些轉變並非孤立存在；它們相互作用，重塑了急性護理、門診護理和研究環境中的產品藍圖、報銷策略和臨床工作流程。

對 2025 年美國關稅變化將如何改變設備類別的採購動態、供應鏈和製造商策略的策略評估。

2025年推出的關稅調整產生了複雜的後果，波及整個腦監測設備價值鏈。關鍵零件和完整成像系統的進口關稅增加了醫療保健提供者和研究機構的採購成本，促使採購負責人重新評估供應商選擇標準和整體擁有成本。因此，一些買家正在推遲資本採購，或選擇擁有在地化製造地的供應商，以減輕關稅的影響。

這些變化正在波及各個產品類型。資本密集系統，例如先進的磁振造影平台和整合式PET解決方案，對零件價格上漲和物流限制特別敏感。同時，配件和耗材（例如帽蓋、電極和感測器）的生態系統正面臨巨大的利潤壓力，迫使經銷商和醫院供應經理重新協商合約或尋找替代供應商。對於以軟體為中心的供應商而言，運算硬體和周邊設備的關稅將影響捆綁產品的部署策略，尤其是包含邊緣處理單元和專用伺服器的產品。

製造商正在透過策略轉變來應對，包括近岸生產、多元化供應商基礎以及重新設計產品設計，以減少對受關稅影響零件的依賴。這些策略轉變通常需要前期投資以及庫存和物流實踐的調整。在預算受限的環境中，例如公立醫院和某些研究機構，對研究的影響更大，因為這些機構可能優先考慮成本控制，而不是儘早採用現代方法。總而言之，2025 年的關稅趨勢正在加速供給側重小組，引發需求面警惕，並重塑整個生態系統的採購計畫和產品策略。

全面的細分洞察映射技術、應用、最終用戶和產品類型，以指導有針對性的產品開發和商業化策略

詳細了解細分對於指導整個腦監測市場的產品開發、商業化和臨床實施策略至關重要。技術包括電腦斷層掃描、腦電圖、功能性近紅外線光譜、磁振造影、腦磁圖和正子斷層掃描，每種技術都有不同的技術特點和臨床效用。電腦斷層掃描分為錐狀射束CT、常規 CT 和頻譜CT，它們的空間解析度、劑量特徵和應用重點各不相同。腦電圖涵蓋動態腦電圖、連續腦電圖監測、常規腦電圖和睡眠腦電圖。動態模式進一步分為不穿戴式和穿戴式，穿戴式設備細分為帽式和頭帶式，以優先考慮全面覆蓋或用戶便利性。功能性近紅外線光譜分為連續波、頻域和時域技術。頻域方法進一步細分為多距離和單距離配置，這會影響深度靈敏度和量化。磁振造影包括常規、高場和低場 MRI，其中高場系統進一步細分為標準高場和超高場平台，可提供增強的對比度和解析度。腦磁圖分為基於光激發磁強計的系統和基於 SQUID 的系統，OPM 平台進一步分為環境場 OPM 和零場 OPM。正子斷層掃描包括整合 PET/CT、混合 PET/MRI 和獨立 PET 系統，每種系統都針對不同的診斷工作流程進行了最佳化。

應用分析揭示了三個主要用例：臨床診斷、居家醫療和研究。臨床診斷優先考慮穩健性、法規核准以及與現有護理路徑的整合。居家醫療強調易用性、舒適性和遠端資料傳輸功能，以支援縱向監測和慢性病管理。研究應用需要靈活性、原始資料存取能力以及適合實驗通訊協定的模式。

最終用戶涵蓋診斷中心、居家醫療機構、醫院和研究機構，後者細分為政府和私人實體，具有不同的採購週期和融資模式：診斷中心通常注重吞吐量和成本效率，醫院注重多功能性和與電子健康記錄的整合，居家照護注重患者體驗和遠端監控基礎設施，研究機構注重客製化和資料保真度。

產品類型涵蓋配件、軟體和系統。配件包括直接影響訊號品質和患者舒適度的帽蓋、電極和感測器。軟體包括核心分析和資料管理軟體，可將生理訊號轉化為臨床洞察，並實現安全的長期資料儲存。系統分為可攜式和固定式，反映了便攜性和先進成像性能之間的權衡。同時了解這些細分維度，有助於相關人員識別創新利基市場，確定證據產生的優先級，並根據每個購買群體的具體需求定製商業策略。

針對特定地區的見解，解釋醫療保健基礎設施、管理體制和製造業足跡將如何影響世界各地的採用模式

由於醫療基礎設施、法規環境和研發生態系統的差異，各區域的動態呈現不同的模式。美洲地區擁有強大的臨床研究基礎，對先進診斷和監測能力的需求旺盛，尤其注重能夠融入醫院工作流程並支持門診病人擴張的解決方案。報銷框架和臨床醫生對先進成像模式的熟悉程度將影響其應用速度，同時，各地區正在考慮採取本地製造舉措，以緩解關稅帶來的成本壓力。

雖然協調一致的監管環境有利於歐洲、中東和非洲地區的跨境設備核准，但不同的醫療保健預算和基礎設施造就了不同的市場利基。在該地區的部分地區，公共衛生計畫和學術研究中心正在推動對多功能系統和靈活採購模式的需求，而其他市場則優先考慮適合分散式醫療保健服務的經濟高效、可攜式的解決方案。對於在這一廣闊地區運作的供應商來說，供應鏈的彈性和對不同管理體制的合規性是關鍵考慮因素。

亞太地區的特點是創新設備快速普及，並擁有強大的製造基礎，支援原始設備製造商 (OEM) 生產和零件供應。患者人數眾多的大型城市中心正推動著人們對高通量診斷技術的興趣，而該地區的新興市場則優先考慮低成本、易於部署的系統和遠端監控技術，以解決醫療服務取得方面的差異。在這個多元化的市場格局中，建立區域夥伴關係並融入當地監管環境是進入和拓展市場的有效策略。

整體而言，區域策略需要在定價、證據產生和服務模式等方面平衡全球產品標準化與在地化。製造商若能將其產品藍圖與特定地區的報銷、監管和臨床實踐情況相結合，將能夠在全部區域獲得更廣泛的應用。

細緻檢視競爭定位、夥伴關係模式和策略舉措，這些決定了大腦監測生態系統的領導力和差異化

腦監測設備生態系的競爭動態由老字型大小企業、專業的神經技術新興企業、軟體分析供應商和組件供應商組成。現有企業通常基於廣泛的系統組合、服務網路和深度臨床檢驗展開競爭，而專業供應商則專注於利基性能優勢、創新的外形尺寸或針對特定臨床工作流程的軟體驅動差異化。新興企業通常會推動穿戴式腦電圖 (EEG)、可攜式腦磁圖 (MEG) 和非侵入式光學感測的快速迭代，而軟體優先的公司則強調分析、雲端連接和互通性，以開拓新的用例。

設備製造商與分析提供者之間的夥伴關係加速了原始訊號向決策輸出的轉化，而與研究實驗室的合作則能夠進行支援臨床應用的嚴格檢驗研究。同樣，零件供應商和契約製造製造商在確定產品成本結構和上市時間方面也發揮關鍵作用，尤其是在企業應對供應鏈壓力和關稅主導的成本變化時。

隨著企業尋求擴展自身能力或進入相關臨床領域，諸如定向收購、授權協議和共同開發契約等策略性企業行動變得十分常見。服務和維護產品、培訓計劃和託管服務已成為提升客戶維繫和終身價值的關鍵差異化因素。總體而言，競爭格局有利於那些將卓越技術能力與可擴展的商業化模式以及強大的臨床夥伴關係關係相結合的企業。

為高階主管提供有針對性的、可操作的建議，以增強供應彈性，加速軟體主導的差異化，並使證據策略與商業性目標保持一致

產業領導者應奉行平衡的策略，將產品創新與現實的商業性和業務需求結合。首先，多元化供應鏈並評估關鍵零件的近岸外包，可以減少關稅波動帶來的風險，並提高應對力。製造商應優先考慮模組化產品架構，以便根據不同的臨床或區域需求進行組件替換和快速配置。這種工程彈性可以加快產品上市時間，並減輕供應中斷的影響。

其次，投資強大的軟體和分析能力至關重要。軟體不僅可以透過改善解讀和工作流程整合來提升設備的價值，還能創造經常性商機並增強客戶保留率。領導者應建立支援標準化資料格式、安全雲端連接和以臨床醫生為中心的介面的互通平台，以推動其在醫院、診斷中心和居家醫療機構的採用。

第三，證據生成和監管策略必須緊密結合。優先進行能夠證明真實世界效用、成本效益和以患者為中心的臨床研究，可以簡化付款方參與度並支持報銷談判。儘早與監管機構和付款方溝通，可以使核准和報銷流程更加可預測。此外，公司應擴展其服務範圍和培訓項目，以確保最佳的臨床整合，並減輕最終用戶的負擔。

最後，與研究機構、本地經銷商和技術供應商建立策略夥伴關係正在加速市場進入和規模擴張。結合硬體、軟體和臨床專業知識的合作舉措在持續監測、重症加護和家庭慢性病管理等專業領域尤其有效地展現了價值。透過結合營運彈性、軟體差異化、臨床證據和協作式打入市場策略，產業領導者能夠應對當前的逆境，並抓住不同護理環境中的成長機會。

透明的調查方法結合了主要相關人員訪談、技術檢驗和情境分析，為相關人員提供了可操作的、基於證據的見解

本分析背後的調查方法結合了專家的初步研究、嚴格的技術檢驗和全面的二次檢驗，以確保獲得可靠且可操作的見解。主要輸入包括與臨床醫生、生物醫學工程師、採購專業人員和設備開發人員進行結構化訪談，以掌握臨床效用、採購標準和技術採用障礙的第一手觀點。這些對話有助於理解現實世界的工作流程和未滿足的需求，從而確定設備需求和證據優先順序。

二次分析整合了同行評審文獻、監管核准和指導文件、專利申請以及臨床試驗註冊，以評估技術成熟度並檢驗性能和安全性聲明。供應鏈映射和組件級評估可直覺地呈現製造依賴、物流路徑和潛在瓶頸。比較技術評估則評估不同模式在敏感度、特異性、易用性和整合複雜性方面的權衡。

情境分析探討政策轉變、資費變化和技術突破對採用途徑和採購決策的影響。檢驗跨時間的多個資料流，確保結論有理有據，並基於現實約束提出建議。在調查方法中，我們始終強調支持採用、法規核准和臨床整合的假設和證據的透明度。

堅定的策略結論，強調技術前景、營運彈性和以證據為導向的商業化之間的交匯，以實現長期影響

總而言之，在技術微型化、進階分析和轉向分散式照護模式的推動下，腦監測設備領域正在經歷一場關鍵性的變革時期。這些力量為可攜式、穿戴式式和多模態解決方案創造了新的機遇，這些解決方案可以將監測範圍從醫院擴展到門診和居家照護。同時，政策變化和關稅調整給供應鏈和採購帶來壓力，迫使製造商和買家重新思考其採購、產品架構和定價策略。

在這種環境下取得成功，取決於將工程靈活性與強大的軟體功能相結合，並採用嚴謹的證據生成策略，以充分考慮臨床醫生、付款人和採購部門的需求。美洲、中東和非洲以及亞太地區的採用路徑各不相同，需要公司根據區域監管、報銷和基礎設施的實際情況量身定做方案。專注於模組化、互通性、臨床檢驗和供應彈性，將使相關人員能夠將新興技術前景轉化為可擴展的臨床影響和永續的商業模式。

最終，整合創新、實際商業化和策略夥伴關係關係的組織將最有能力為神經系統護理帶來有意義的改善，並抓住臨床和研究領域的長期機會。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合人工智慧驅動的腦電圖分析，實現個人化神經診斷與治療監測
  • 開發穿戴式腦電圖頭帶，能夠持續即時監測壓力和心理健康
  • 用於遠距神經復健治療的非侵入式腦機介面平台的實現
  • 採用雲端基礎的數據平台進行可擴展的腦波訊號捕獲和進階分析
  • 乾電極感測器的出現提高了長期腦活動監測的舒適度和準確性
  • 利用腦電圖資料進行認知訓練與娛樂的神經回饋遊戲應用的成長
  • 更新後的監管指南加強了消費者腦監測設備製造商的合規要求
  • 擴展遠距遠端醫療腦電圖服務，用於遠距患者腦功能評估

第6章 2025年美國關稅的累積影響

第7章 人工智慧的累積影響，2025年

第8章腦監測設備市場（按技術）

  • CT
    • 錐狀射束CT
    • 常規CT
    • 頻譜CT
  • 腦電圖（EEG）
    • 動態腦電圖
      • 不穿戴式
      • 穿戴式裝置
      • 帽底
      • 頭帶底座
    • 持續腦電圖監測
    • 常規腦電圖
    • 睡眠腦電圖
  • FNIRS
    • 連續波
    • 頻域
      • 多距離
      • 單程
    • 時間域
  • 磁振造影
    • 常規MRI
    • 高場磁振造影
      • 標準高度場
      • 超高磁場
    • 低場磁振造影
  • 腦磁圖
    • 基於OPM
      • 周邊 OPM
      • 零場 OPM
    • 基於SQUID
  • PET
    • PET/CT
    • PET/MRI
    • 獨立 PET

第9章腦監測設備市場（按應用）

  • 臨床診斷
  • 居家醫療
  • 研究

第 10 章腦監測設備市場（依最終用戶）

  • 診斷中心
  • 居家照護
  • 醫院
  • 研究所
    • 政府機構
    • 私人機構

第 11 章腦監測設備市場（依產品類型）

  • 配件
    • 帽子
    • 電極
    • 感應器
  • 軟體
    • 分析軟體
    • 資料管理軟體
  • 系統
    • 可攜式系統
    • 固定系統

第12章腦監測設備市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章腦監測設備市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章腦監測設備市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Koninklijke Philips NV
    • Medtronic plc
    • General Electric Company
    • Nihon Kohden Corporation
    • Natus Medical Incorporated
    • Compumedics Limited
    • Cadwell Laboratories, Inc.
    • g.tec medical engineering GmbH
    • Brain Products GmbH
    • Natus Medical
Product Code: MRR-437D4595861A

The Brain Monitoring Devices Market is projected to grow by USD 5.15 billion at a CAGR of 7.74% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.84 billion
Estimated Year [2025] USD 3.06 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 7.74%

A concise and forward-looking introduction to the shifting technological, clinical, and care delivery forces reshaping brain monitoring across clinical and research settings

The landscape of brain monitoring devices is evolving rapidly as advances in sensing technology, computational analytics, and care delivery models converge to redefine neurological assessment and continuous monitoring. Clinicians are seeking tools that deliver higher diagnostic confidence while fitting into increasingly decentralized care pathways. At the same time, researchers and device developers are pushing for modalities that reduce barriers to access, improve patient comfort, and extend monitoring beyond episodic encounters into longitudinal, real-world data capture.

In parallel, improvements in signal processing, miniaturized sensors, and low-field imaging platforms are creating opportunities for new device form factors and use cases. These technological enablers are further amplified by the maturation of software-driven analytics, which transform raw physiological signals into actionable insights for diagnosis, treatment planning, and outcome tracking. As a result, stakeholders across healthcare, research, and home care contexts are reevaluating clinical workflows and procurement priorities to incorporate solutions that balance performance, usability, and cost-effectiveness.

Regulatory pathways and reimbursement environments are also adapting, prompting manufacturers and healthcare providers to align product development and evidence-generation strategies closely with clinical needs. Collectively, these dynamics are accelerating the transition from purely hospital-centric imaging and monitoring to hybrid models that integrate hospital, outpatient, and home-based monitoring, thereby expanding the role of brain monitoring devices in both acute and chronic care management.

An in-depth account of the converging technological innovations, analytics breakthroughs, and care delivery shifts that are transforming brain monitoring capabilities and adoption

Recent years have seen a series of transformative shifts that are redefining what brain monitoring devices can achieve and where they can be deployed. A primary shift is the transition from large, stationary instruments toward portable and wearable platforms that enable continuous or ambulatory monitoring outside traditional clinical environments. This movement is accompanied by a proliferation of multimodal approaches that combine electroencephalography with optical, magnetic, and metabolic imaging to provide complementary perspectives on brain function.

Another major transformation is the integration of advanced analytics, including machine learning and cloud-based pipelines, which convert complex physiological datasets into clinically relevant outputs. These analytics enable faster interpretation, pattern recognition across large cohorts, and predictive modeling that supports early intervention. Concurrently, hardware innovations-such as compact sensor arrays, low-field magnetic resonance imaging systems, and optically pumped magnetometers-are lowering the barriers to adoption by reducing cost, footprint, and operational complexity.

Ecosystem-level changes are also notable. The proliferation of home care and ambulatory applications is shifting centricity toward patient convenience and long-term monitoring, necessitating stronger emphasis on device comfort, data security, and remote device management. Supply chain diversification and onshoring initiatives are influencing manufacturing strategies, while evolving regulatory expectations demand robust clinical validation and post-market surveillance. Taken together, these shifts are not isolated; they compound each other to reshape product roadmaps, reimbursement strategies, and clinical workflows across acute care, outpatient settings, and research environments.

A strategic assessment of how the United States tariff changes in 2025 altered procurement dynamics, supply chains, and manufacturer strategies across device categories

The tariff adjustments introduced in the United States in 2025 have created a complex set of consequences that reverberate across the brain monitoring device value chain. Import levies on key components and finished imaging systems have increased procurement costs for healthcare providers and research institutions, prompting procurement officers to reassess vendor selection criteria and total cost of ownership. As a result, some buyers are delaying capital purchases or favoring suppliers with localized manufacturing footprints to mitigate tariff exposure.

These changes have ripple effects across product categories. High-capital systems, including advanced magnetic resonance platforms and integrated PET solutions, face particular sensitivity to component price inflation and logistics constraints. At the same time, the accessories and consumables ecosystem-caps, electrodes, sensors-has experienced tighter margin pressure, which challenges distributors and hospital supply managers to renegotiate contracts or seek alternative suppliers. For software-centric vendors, tariffs on computing hardware and peripheral devices affect deployment strategies, particularly for bundled offerings that include edge processing units or specialized servers.

Manufacturers are responding with strategic shifts that include nearshoring of production, diversification of supplier bases, and reengineering of product designs to reduce dependency on tariffed components. These strategic moves often require upfront capital and a recalibration of inventory and logistics practices. Procurement implications are amplified in settings where budgets are constrained, such as public hospitals and certain research institutes, which may prioritize cost containment over early adoption of the latest modalities. In sum, the 2025 tariff landscape has accelerated supply-side restructuring and introduced demand-side caution, reshaping procurement timelines and product strategies across the ecosystem.

Comprehensive segmentation insights that map technologies, applications, end users, and product types to guide targeted product development and commercialization strategies

A granular understanding of segmentation is essential to navigate product development, commercialization, and clinical adoption strategies across the brain monitoring landscape. From a technology perspective, the market encompasses computed tomography, electroencephalography, functional near-infrared spectroscopy, magnetic resonance imaging, magnetoencephalography, and positron emission tomography, each with distinct technical attributes and clinical utilities. Computed tomography is differentiated across cone beam CT, conventional CT, and spectral CT, which vary in spatial resolution, dose characteristics, and application focus. Electroencephalography spans ambulatory EEG, continuous EEG monitoring, routine EEG, and sleep EEG, with ambulatory modalities further bifurcating into non-wearable and wearable formats, and wearable devices subdivided into cap-based and headband-based designs that prioritize either comprehensive coverage or user convenience. Functional near-infrared spectroscopy is divided into continuous wave, frequency domain, and time domain technologies, with frequency domain approaches further differentiated by multi-distance and single-distance configurations that affect depth sensitivity and quantification. Magnetic resonance imaging includes conventional MRI, high field MRI, and low field MRI, where high field systems are further distinguished between standard high field and ultra high field platforms that drive advanced contrast and resolution. Magnetoencephalography is distinguished between optically pumped magnetometer-based systems and SQUID-based systems, with OPM platforms further categorized into ambient OPM and zero field OPM variants. Positron emission tomography offerings include integrated PET/CT, hybrid PET/MRI, and standalone PET systems, each optimized for different diagnostic workflows.

Analyzing applications reveals three primary use cases: clinical diagnostics, home care, and research. Clinical diagnostics prioritize robustness, regulatory clearance, and integration into established care pathways. Home care emphasizes ease of use, comfort, and remote data transmission capabilities to support longitudinal monitoring and chronic disease management. Research applications demand flexibility, raw data access, and modalities suited to experimental protocols.

End users cut across diagnostics centers, home care settings, hospitals, and research institutes, with research institutes subdivided into governmental and private entities that have differing procurement cycles and funding models. Diagnostics centers typically focus on throughput and cost-efficiency, hospitals on versatility and integration with electronic health records, home care settings on patient experience and remote monitoring infrastructure, and research institutes on customization and data fidelity.

Product types span accessories, software, and systems. Accessories encompass caps, electrodes, and sensors that directly influence signal quality and patient comfort. Software includes analysis software and data management software, which are core to translating physiological signals into clinical insights and enabling secure longitudinal data storage. Systems are categorized into portable systems and stationary systems, reflecting trade-offs between mobility and advanced imaging performance. Understanding these segmentation dimensions in tandem enables stakeholders to identify niches for innovation, prioritize evidence generation, and tailor commercial strategies to the specific demands of each buyer group.

Region-specific insights describing how differing healthcare infrastructure, regulatory regimes, and manufacturing footprints dictate adoption patterns across global territories

Regional dynamics exhibit distinct patterns driven by differences in healthcare infrastructure, regulatory environments, and R&D ecosystems. The Americas reflect a strong clinical research base and high demand for advanced diagnostic and monitoring capabilities, with emphasis on solutions that integrate into hospital workflows and support outpatient expansions. Reimbursement frameworks and clinician familiarity with advanced imaging modalities influence adoption velocity, and localized manufacturing initiatives are being explored to mitigate tariff-driven cost pressures.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in certain areas supports cross-border device approvals, yet varying healthcare budgets and infrastructure create distinct market niches. In parts of this region, public health programs and academic research centers drive demand for versatile systems and flexible acquisition models, while other markets prioritize cost-effective, portable solutions suitable for decentralized care delivery. Supply chain resilience and compliance with diverse regulatory regimes are key considerations for vendors operating across this broad region.

Asia-Pacific is characterized by rapid adoption of innovative device form factors and a robust manufacturing base that supports both original equipment production and component supply. Large urban centers with sizable patient volumes drive interest in high-throughput diagnostics, while emerging markets within the region prioritize low-cost, easy-to-deploy systems and remote monitoring technologies to address access gaps. Regional partnerships and local regulatory engagement are effective strategies for market entry and scale in this diverse landscape.

Taken together, regional strategies must balance global product standardization with local adaptations in pricing, evidence generation, and service models. Manufacturers that align product roadmaps with region-specific reimbursement, regulatory, and clinical practice realities are positioned to capture broader adoption across these distinct geographies.

A nuanced view of competitive positioning, partnership models, and strategic moves that define leadership and differentiation within the brain monitoring ecosystem

Competitive dynamics in the brain monitoring device ecosystem are shaped by a mix of established imaging and diagnostics firms, specialized neurotechnology startups, software analytics vendors, and component suppliers. Established firms typically compete on the basis of broad systems portfolios, service networks, and deep clinical validation, whereas specialist vendors focus on niche performance advantages, innovative form factors, or software-enabled differentiation that targets specific clinical workflows. Startups often drive rapid iteration in wearable EEG, portable MEG, and noninvasive optical sensing, while software-first companies emphasize analytics, cloud connectivity, and interoperability to unlock new use cases.

Collaboration is a defining feature of the landscape: partnerships between device manufacturers and analytics providers accelerate the translation of raw signals into decision-ready outputs, and alliances with research institutes enable rigorous validation studies that support clinical adoption. Similarly, component suppliers and contract manufacturers play a critical role in determining product cost structures and time-to-market, especially as firms respond to supply chain pressures and tariff-driven cost shifts.

Strategic corporate actions such as targeted acquisitions, licensing deals, and co-development agreements are common as companies seek to expand capabilities or enter adjacent clinical segments. Service and maintenance offerings, training programs, and managed services have emerged as important differentiators that enhance customer retention and lifetime value. Overall, the competitive environment rewards organizations that combine technical excellence with scalable commercialization models and strong clinical partnerships.

Targeted and actionable recommendations for executives to strengthen supply resilience, accelerate software-driven differentiation, and align evidence strategies with commercial goals

Industry leaders should pursue a balanced strategy that aligns product innovation with pragmatic commercial and operational imperatives. First, diversifying supply chains and evaluating nearshoring for critical components will reduce exposure to tariff volatility and improve responsiveness. Manufacturers should prioritize modular product architectures that allow substitution of components and facilitate rapid configuration for different clinical and regional requirements. This engineering flexibility will accelerate time-to-market and lower the impact of supply disruptions.

Second, investing in robust software and analytics capabilities is essential. Software not only enhances device value through improved interpretation and workflow integration, but also creates recurring revenue opportunities and strengthens customer lock-in. Leaders should build interoperable platforms that support standardized data formats, secure cloud connectivity, and clinician-centric interfaces to facilitate adoption across hospitals, diagnostics centers, and home care settings.

Third, evidence generation and regulatory strategy must be tightly coordinated. Prioritizing clinical studies that demonstrate real-world utility, cost-effectiveness, and patient-centered outcomes will streamline payer engagement and support reimbursement discussions. Engaging early with regulators and payers enables more predictable pathways for clearance and coverage. Additionally, companies should expand service offerings and training programs to ensure optimal clinical integration and to reduce the burden on end users.

Finally, strategic partnerships with research institutes, local distributors, and technology providers can accelerate market entry and scale. Joint initiatives that combine hardware, software, and clinical expertise will be particularly effective in demonstrating value in specialty areas such as continuous monitoring, neurocritical care, and home-based chronic disease management. By aligning operational resilience, software differentiation, clinical evidence, and collaborative go-to-market strategies, industry leaders can navigate current headwinds and capture growth opportunities across diverse care settings.

A transparent methodology combining primary stakeholder interviews, technical validation, and scenario analysis to produce actionable and evidence-based insights for stakeholders

The research methodology underpinning this analysis combines primary engagement with domain experts, rigorous technical review, and comprehensive secondary validation to ensure robust and actionable insights. Primary inputs include structured interviews with clinicians, biomedical engineers, procurement professionals, and device developers to capture firsthand perspectives on clinical utility, procurement criteria, and technology adoption barriers. These conversations inform an understanding of real-world workflows and unmet needs that shape device requirements and evidence priorities.

Secondary analysis synthesizes peer-reviewed literature, regulatory approvals and guidance documents, patent filings, and clinical trial registries to assess technology maturity and validate claims about performance and safety. Supply chain mapping and component-level assessment provide visibility into manufacturing dependencies, logistics pathways, and potential bottlenecks. Comparative technology assessments evaluate trade-offs among modalities in terms of sensitivity, specificity, usability, and integration complexity.

Scenario-based analysis explores the implications of policy shifts, tariff changes, and technological breakthroughs on adoption pathways and procurement decisions. Cross-validation across multiple data streams ensures that conclusions are corroborated and that recommendations remain grounded in practical constraints. Throughout, the methodology emphasizes transparency in assumptions and a focus on evidence that supports adoption, regulatory clearance, and integration into clinical practice.

A decisive and strategic conclusion emphasizing the intersection of technological promise, operational resilience, and evidence-driven commercialization for long-term impact

In conclusion, the brain monitoring device landscape is undergoing a pivotal transformation driven by technological miniaturization, advanced analytics, and a shift toward decentralized care models. These forces are creating new opportunities for portable, wearable, and multimodal solutions that can extend monitoring beyond hospitals into outpatient and home care settings. At the same time, policy changes and tariff adjustments are exerting pressure on supply chains and procurement, prompting manufacturers and buyers to rethink sourcing, product architecture, and pricing strategies.

The ability to succeed in this environment depends on aligning engineering flexibility with strong software capabilities and a disciplined evidence-generation strategy that speaks to clinicians, payers, and procurement authorities. Regional nuances matter: adoption pathways differ across the Americas, Europe, Middle East & Africa, and Asia-Pacific, and companies must tailor approaches to local regulatory, reimbursement, and infrastructure realities. By focusing on modularity, interoperability, clinical validation, and supply resilience, stakeholders can translate emerging technological promise into scalable clinical impact and sustainable commercial models.

Ultimately, the organizations that integrate technical innovation with pragmatic commercialization and strategic partnerships will be best positioned to deliver meaningful improvements in neurological care and to capture long-term opportunities across clinical and research domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven EEG analysis for personalized neurological diagnostics and therapeutic monitoring
  • 5.2. Development of wearable EEG headbands enabling continuous stress and mental health monitoring in real time
  • 5.3. Implementation of non-invasive brain-computer interface platforms for remote neurorehabilitation therapy
  • 5.4. Adoption of cloud-based data platforms for scalable brain signal capture and advanced analytics
  • 5.5. Emergence of dry electrode sensors improving comfort and long-term brain activity monitoring accuracy
  • 5.6. Growth in neurofeedback gaming applications leveraging brainwave data for cognitive training and entertainment
  • 5.7. Regulatory guidance updates driving compliance requirements for consumer brain monitoring device manufacturers
  • 5.8. Expansion of telehealth-enabled EEG services for remote patient brain function assessment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Monitoring Devices Market, by Technology

  • 8.1. CT
    • 8.1.1. Cone Beam CT
    • 8.1.2. Conventional CT
    • 8.1.3. Spectral CT
  • 8.2. Electroencephalography
    • 8.2.1. Ambulatory EEG
      • 8.2.1.1. Non Wearable
      • 8.2.1.2. Wearable
      • 8.2.1.2.1. Cap Based
      • 8.2.1.2.2. Headband Based
    • 8.2.2. Continuous EEG Monitoring
    • 8.2.3. Routine EEG
    • 8.2.4. Sleep EEG
  • 8.3. FNIRS
    • 8.3.1. Continuous Wave
    • 8.3.2. Frequency Domain
      • 8.3.2.1. Multi Distance
      • 8.3.2.2. Single Distance
    • 8.3.3. Time Domain
  • 8.4. Magnetic Resonance Imaging
    • 8.4.1. Conventional MRI
    • 8.4.2. High Field MRI
      • 8.4.2.1. Standard High Field
      • 8.4.2.2. Ultra High Field
    • 8.4.3. Low Field MRI
  • 8.5. Magnetoencephalography
    • 8.5.1. OPM Based
      • 8.5.1.1. Ambient OPM
      • 8.5.1.2. Zero Field OPM
    • 8.5.2. SQUID Based
  • 8.6. PET
    • 8.6.1. PET/CT
    • 8.6.2. PET/MRI
    • 8.6.3. Standalone PET

9. Brain Monitoring Devices Market, by Application

  • 9.1. Clinical Diagnostics
  • 9.2. Home Care
  • 9.3. Research

10. Brain Monitoring Devices Market, by End User

  • 10.1. Diagnostics Centers
  • 10.2. Home Care Settings
  • 10.3. Hospitals
  • 10.4. Research Institutes
    • 10.4.1. Government Institutes
    • 10.4.2. Private Institutes

11. Brain Monitoring Devices Market, by Product Type

  • 11.1. Accessories
    • 11.1.1. Caps
    • 11.1.2. Electrodes
    • 11.1.3. Sensors
  • 11.2. Software
    • 11.2.1. Analysis Software
    • 11.2.2. Data Management Software
  • 11.3. Systems
    • 11.3.1. Portable Systems
    • 11.3.2. Stationary Systems

12. Brain Monitoring Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Monitoring Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Monitoring Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Koninklijke Philips N.V.
    • 15.3.2. Medtronic plc
    • 15.3.3. General Electric Company
    • 15.3.4. Nihon Kohden Corporation
    • 15.3.5. Natus Medical Incorporated
    • 15.3.6. Compumedics Limited
    • 15.3.7. Cadwell Laboratories, Inc.
    • 15.3.8. g.tec medical engineering GmbH
    • 15.3.9. Brain Products GmbH
    • 15.3.10. Natus Medical

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRAIN MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BRAIN MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BRAIN MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY GROUP,